Identification | Back Directory | [Name]
Honokiol | [CAS]
564-73-8 | [Synonyms]
Hikiol Hinokiol (2S)-1,2,3,4,4a,9,10,10aα-Octahydro-1,1,4aβ-trimethyl-7-isopropyl-2β,6-phenanthrenediol 2,6-Phenanthrenediol, 1,2,3,4,4a,9,10,10a-octahydro-1,1,4a-trimethyl-7-(1-methylethyl)-, (2S,4aS,10aR)- | [Molecular Formula]
C20H30O2 | [MOL File]
564-73-8.mol | [Molecular Weight]
302.45 |
Hazard Information | Back Directory | [Description]
Hinokiol demonstrates potent activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Hinokiol has significant inhibitory effects on 5-hydroxy-eicosa-tetra-enoic acid (5-HETE) and leukotriene B(4) (LTB4) formations, suggests that it has anti-inflammatory activity. | [target]
LOX | NO | TNF-α | COX | Antifection |
|
Company Name: |
BioBioPha Co., Ltd.
|
Tel: |
0871-65217109 13211707573; |
Website: |
http://www.biobiopha.com |
Company Name: |
BOC Sciences
|
Tel: |
|
Website: |
https://www.bocsci.com |
|